Karl Deisseroth, the Nobel psychiatrist who never stopped seeing patients

Karl Deisseroth

Photo: Christopher Michel / CC BY-SA 4.0, via Wikimedia Commons

Born	November 18, 1971 Boston
Occupation	Psychiatrist
Awards	Albany Medical Center Prize · Dickson Prize in Medicine · Massry Prize

Most laureates in medicine stopped treating patients long before the phone rang from Stockholm. Karl Deisseroth never did. The Stanford scientist who gave neuroscience a way to switch chosen brain cells on and off with a flash of blue light still sits across from people with severe psychiatric illness and listens to them try to put into words states that resist description. He says those conversations feed straight back into what his laboratory tests next. The Nobel Prize he now shares rewards the tool. The clinic is where the questions that tool was built to answer keep coming from.

The method is called optogenetics, a name he coined himself. It borrows channelrhodopsin, a protein from a single-celled green alga that opens a pore when light strikes it. Put the gene for that protein into a selected group of neurons and those cells fire on command, with millisecond timing, while their neighbors stay quiet. For a discipline that had spent generations matching brain regions to behavior by watching what broke when they were damaged, it meant a researcher could finally ask a causal question: turn this circuit on, and what does the animal do? “We’re not using light to collect information, we’re using light to cause things to happen,” he told STAT on the morning of the announcement.

Deisseroth was born in Boston on 18 November 1971, the son of the oncologist Albert Deisseroth, and finished school in Houston at St. John’s School in 1988. He studied biochemical sciences at Harvard, graduating in 1992, then moved west to Stanford, where he earned a doctorate in neuroscience in 1998 in Richard Tsien’s laboratory and a medical degree in 2000. Psychiatry, he has said, was not even on the map when he began medicine. The residency changed that. On the wards he met conditions that his profession could describe in detail and explain only vaguely, and the gap between the two became his research agenda.

He opened his own Stanford laboratory in 2004. In July of that year his notebook recorded the first light-triggered activity in neurons carrying channelrhodopsin, the protein Peter Hegemann and Georg Nagel had characterized in algae. The paper followed in Nature Neuroscience in 2005, with Ed Boyden as first author and Feng Zhang, Ernst Bamberg and Nagel among the co-authors. That same year the National Institutes of Health gave him a Director’s Pioneer Award. He named the field in 2006, and by 2007 the switch worked inside the brains of living mice. In 2010 the journal Nature Methods named optogenetics its Method of the Year. He has been a Howard Hughes Medical Institute investigator since 2009.

A second invention came out of the same lab. In 2013 Deisseroth was senior author on the paper describing CLARITY, developed with his postdoctoral fellow Kwanghun Chung and the neuroscientist Viviana Gradinaru: a way to turn an intact brain into a transparent hydrogel that light and molecular probes can pass through. Later variants of that hydrogel-tissue chemistry, such as STARmap, read out gene activity cell by cell in three dimensions without slicing the tissue apart. Alongside both lines of work, his group and Hegemann’s solved high-resolution structures of channelrhodopsins, explaining how the pore selects ions and colors of light.

The prize announced on 5 October 2026 by the Nobel Assembly at the Karolinska Institutet split the honour between Deisseroth, Hegemann and Nagel “for their discoveries concerning light-gated ion channels and optogenetics”. The rules cap a Nobel at three names, and the cap left people out. Boyden, now at MIT, drew the loudest objections from commentators on social media after the announcement; he did not respond to requests for comment. The committee’s own background material credits other pioneers, including Gero Miesenböck, who first made ordinary neurons sensitive to light in 2002, and Zhuo-Hua Pan, who tested channelrhodopsin in retinal cells. Deisseroth has handled the priority question more openly than most: he published the July 2004 notebook pages and routinely names the laboratories, among them those of Stefan Herlitze, Alexander Gottschalk, Hiromu Yawo and Pan, that reached similar results within the following year. There is a second caveat the celebrations tend to skip. For all its reach in the laboratory, the Nobel committee’s own account of clinical use points only to attempts to restore sight in people with visual impairment. The psychiatric payoff his patients might hope for remains a research programme.

He has also tried to explain what the circuits mean for the people he treats. Projections, published by Random House in 2021, moves between encounters with patients and the neural circuitry behind emotions, and argues that psychiatric states sit on a spectrum rooted in evolutionary history. The title plays on both of its meanings: the defense mechanism psychiatrists recognize, and the long fibres a neuron sends to a distant target.

The Nobel call reached him after midnight in California. He had been working late on a paper and had just lain down, and he was the first of the three laureates the committee reached. In the interview he recorded that night, with the rest of the household asleep, he described a recent line of work in which his team paced the hearts of mice with light to watch how heart rate shifts brain states and behavior, communication from body to brain with the precision of a switch. He was 55 when the prize was announced. He called his co-laureates frequent collaborators and friends, people with whom he had shared papers, conferences and beers over many years.

The Nobel caps a run of recognition that already included the Lasker Basic Medical Research Award in 2021, shared with Hegemann and Dieter Oesterhelt; the Kyoto Prize in 2018, of which he became the youngest recipient; the Canada Gairdner International Award the same year; the Harvey Prize with Hegemann in 2016; the Breakthrough Prize in Life Sciences; and the Brain Prize in 2013, which he shared with five other optogenetics researchers, Boyden among them. He is a member of the national academies of sciences, engineering and medicine of the United States.

He is married to Michelle Monje, a Stanford neuroscientist, with whom he has four children; he also has a son from an earlier relationship. He holds the D.H. Chen professorship in bioengineering at Stanford alongside his professorship in psychiatry and behavioral sciences, and works as an attending physician at Stanford’s hospital.

The ceremony in Stockholm is set for 10 December. After it, by his own account, the routine stays the same: late nights on papers, the lab, and the patients whose descriptions of what they feel remain the hardest data he has.

Tags: Georg Nagel, Karl Deisseroth, optogenetics, Peter Hegemann, Stanford University, Ed Boyden

Related People

Related People

Discussion